Correlation Between JAPAN TOBACCO and SCHOTT Pharma
Specify exactly 2 symbols:
By analyzing existing cross correlation between JAPAN TOBACCO UNSPADR12 and SCHOTT Pharma AG, you can compare the effects of market volatilities on JAPAN TOBACCO and SCHOTT Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JAPAN TOBACCO with a short position of SCHOTT Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of JAPAN TOBACCO and SCHOTT Pharma.
Diversification Opportunities for JAPAN TOBACCO and SCHOTT Pharma
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between JAPAN and SCHOTT is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding JAPAN TOBACCO UNSPADR12 and SCHOTT Pharma AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCHOTT Pharma AG and JAPAN TOBACCO is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JAPAN TOBACCO UNSPADR12 are associated (or correlated) with SCHOTT Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCHOTT Pharma AG has no effect on the direction of JAPAN TOBACCO i.e., JAPAN TOBACCO and SCHOTT Pharma go up and down completely randomly.
Pair Corralation between JAPAN TOBACCO and SCHOTT Pharma
Assuming the 90 days trading horizon JAPAN TOBACCO UNSPADR12 is expected to generate 0.68 times more return on investment than SCHOTT Pharma. However, JAPAN TOBACCO UNSPADR12 is 1.46 times less risky than SCHOTT Pharma. It trades about 0.06 of its potential returns per unit of risk. SCHOTT Pharma AG is currently generating about -0.01 per unit of risk. If you would invest 913.00 in JAPAN TOBACCO UNSPADR12 on September 12, 2024 and sell it today you would earn a total of 367.00 from holding JAPAN TOBACCO UNSPADR12 or generate 40.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 86.31% |
| Values | Daily Returns |
JAPAN TOBACCO UNSPADR12 vs. SCHOTT Pharma AG
Performance |
| Timeline |
| JAPAN TOBACCO UNSPADR12 |
| SCHOTT Pharma AG |
JAPAN TOBACCO and SCHOTT Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with JAPAN TOBACCO and SCHOTT Pharma
The main advantage of trading using opposite JAPAN TOBACCO and SCHOTT Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JAPAN TOBACCO position performs unexpectedly, SCHOTT Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCHOTT Pharma will offset losses from the drop in SCHOTT Pharma's long position.| JAPAN TOBACCO vs. British American Tobacco | JAPAN TOBACCO vs. British American Tobacco | JAPAN TOBACCO vs. Japan Tobacco |
| SCHOTT Pharma vs. Tencent Music Entertainment | SCHOTT Pharma vs. Japan Tobacco | SCHOTT Pharma vs. VARIOUS EATERIES LS | SCHOTT Pharma vs. JAPAN TOBACCO UNSPADR12 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |